This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Management

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

General advice includes:

  • adopt a regular sleep routine
  • avoid excess caffeine and alcohol

If daytime sleepiness continues to be a problem then some patients may prefer to take regular naps.

If naps are not possible then most patients will require drug treatment.

  • in general, in patients with narcolepsy, treatment is initiated by a specialist
  • treatments used to increase alertness include dexamfetamine and modafinil, and methylphenidate
    • concomitant treatment with an antidepressant drug (usually clomipramine) may be given to prevent cataplectic attacks
    • in practice, management for idiopathic hypersomnia is similar to that for narcolepsy
    • pitolisant (a wake promoting histamine H3-receptor inverse agonist) may provide a further treatment option (2)

Reference:

  1. Drug and Therapeutics Bulletin 2004; 42(7):52-6.
  2. Brown J, Makker KM. An approach to excessive daytime sleepiness in adults. BMJ 2020;368:m1047

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.